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Conclusions: The use of DJ reduced irradiation of OARs 
positioned in the cranio-caudal border of PTVs. The sparing 
was significant for a small organ (penile bulb) but limited to 
low-dose DVH region for the others. A larger field width (5.0 
vs. 2.5 cm) has led to a significant reduction of delivery time, 
a slightly reduced dose homogeneity in the PTVs, a quite 
similar OARs sparing when only prostate and seminal vesicles 
were treated. A lower sparing for all OARs resulted for WP 
plans DJ_2, but differences were in the range 1.4-2.9 Gy. 
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Purpose/Objective: Pre-treatment verification of Volumetric 
Modulated Arc Therapy (VMAT) is a common practice. MLC 
trajectory records analysis has been suggested as a method 
to appropriately control modulated beam delivery day-to-
day. These trajectory logs consist in a binary file generated 
on a TrueBeam (Varian Medical Systems), containing the 
position expected and actual of many machine parameters, 
such as gantry angle, jaws and leaves positions and fraction 
of overall treatment delivered. These data are collected and 
saved every 20 ms. 
This study analyses the effect of day-to-day MLC position on 
the final dose distribution based on the trajectory log files. 
Materials and Methods: 10 VMAT plans (4 head and neck and 
6 prostates) irradiated with 6MV on a TrueBeam were 
selected. For each plan, trajectory logs for all fractions 
(ranging from 23 to 35) were analyzed and two trajectory 
logs were selected. First the trajectory log with maximum 
root mean square (RMS) of the difference on the position of a 
leave between expected and real position along the fraction 
(from now PosMax) and second, the trajectory log with 
maximum RMS of the difference between expected and real 
gap generated by opposed leaves (GapMax). Using MATLAB (v 
7.12), two new plans were created with the MLC positions, 
gantry angle, and Monitor Units delivered in each control 
point, recorded on PosMax and GapMax files and new dose 
distributions were calculated and compared with the original 
by using Eclipse V.13 (Varian Medical Systems) treatment 
planning system (TPS).  
Results: On table 1 is presented the maximum dose 
difference between plans generated by using the 'PosMax' and 
'GapMax' trajectory logs and the original plan (set as a 
reference). For all dose distributions maximum differences 
were found on the external part of the body. Differences on 
PTV doses were smaller than 2% of the prescribed dose in all 
treatments studied. In all prostate cases dose differences 
were higher on healthy tissue than on PTV, that was not 
observed on the head and neck cases. 
 
Conclusions: Assuming we can rely on trajectory logs as a 
treatment actual delivery (what has to be assured 
independently) no meaningful differences were found 
between planned and delivered dose distributions, although 
the worst scenario was considered. Similar differences were 
found independently of using PosMax or GapMax log files to 
recalculate the dose distributions. Although in all cases 
studied organs at risk met the dosimetric constraints, further 
investigations could be needed to study the actual delivered 
dose in normal tissue. The software developed generates a 
plan with the applied treatment parameters and can 
contribute to a better estimation of the delivered dose on 
the patient. Next stage in our studies will be the calculation 
of these plans on the CBCT images recorded during the 
treatment. 
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